Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

LYR-220 for Adult Subjects With Chronic Rhinosinusitis (BEACON Study)

ClinicalTrials.gov ID: NCT05035654

Public ClinicalTrials.gov record NCT05035654. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 12:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

BEACON: A Phase II, Patient-blinded, Two-part, Randomized, Parallel-group Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of LYR-220 in Chronic Rhinosinusitis (CRS) Patients Who Have Had a Prior Ethmoidectomy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will assess the safety, tolerability, pharmacokinetics and efficacy of two LYR-220 designs in symptomatic adult chronic rhinosinusitis (CRS) subjects who have had a prior functional endoscopic sinus surgery.

Study identification

NCT ID
NCT05035654
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Lyra Therapeutics
Industry
Enrollment
48 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 23, 2021 (Actual)
Primary completion
Aug 30, 2023 (Actual)
Completion
Aug 30, 2023 (Actual)
Last update posted
Dec 17, 2024

2021 – 2023

United States locations

U.S. sites
22
U.S. states
13
U.S. cities
21
Facility City State ZIP Site status
Lyra Investigational Site Carlsbad California 92008 —
Lyra Investigational Site La Mesa California 91942 —
Lyra Investigational Site Roseville California 95661 —
Lyra Investigational Site Torrance California 90501 —
Lyra Investigational Site Chicago Illinois 60208 —
Lyra Investigational Site Chicago Illinois 60657 —
Lyra Investigational Site New Albany Indiana 47150 —
Lyra Investigational Site Louisville Kentucky 40205 —
Lyra Investigational Site Marrero Louisiana 70072 —
Lyra Investigational Site Baltimore Maryland 21204 —
Lyra Investigational Site New Hyde Park New York 11042 —
Lyra Investigational Site New York New York 10016 —
Lyra Investigational Site Chapel Hill North Carolina 27599 —
Lyra Investigational Site Winston-Salem North Carolina 27103 —
Lyra Investigational Site Bethlehem Pennsylvania 18017 —
Lyra Investigational Site Orangeburg South Carolina 29118 —
Lyra Investigational Site Spartanburg South Carolina 29303 —
Lyra Investigational Site Fort Worth Texas 76109 —
Lyra Investigational Site McKinney Texas 75069 —
Lyra Investigational Site San Antonio Texas 78258 —
Lyra Investigational Site South Ogden Utah 84405 —
Lyra Investigational Site Spokane Washington 99201 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05035654, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 17, 2024 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05035654 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →